1-benzyl-5-methylthio-1H-indole | 142769-40-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 1-benzyl-5-methylthio-1H-indole
• 英文别名: 1-Benzyl-5-methylsulfanylindole
• CAS: 142769-40-2
• 化学式: C₁₆H₁₅NS
• 分子量: 253.368
• InChiKey: JHANZBWWZVTJKM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  30.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  N-benzyl-N-(2,2-diethoxyethyl)-4-(methylthio)aniline 在 propylsulfonic acid-functionalized silica 作用下， 以 甲苯 为溶剂， 以97%的产率得到1-benzyl-5-methylthio-1H-indole
  参考文献：
  名称：

  General and efficient synthesis of 2,3-unsubstituted indoles catalyzed by acidic mesoporous molecular sieves

  摘要：

  A general and efficient method for the synthesis of 2,3-unsubstituted indoles has been established by the intramolecular cyclization of N-benzyl 2-anilinoacetals. Acidic mesoporous molecular sieve (MCM-41-SO3H) has shown excellent catalytic activity on this transformation, and the 2,3-unsubstituted indoles bearing 7-substituent or strong electron-withdrawing substituents also could be achieved by this protocol. Moreover, the heterogeneous catalyst, MCM-41-SO3H, could be conveniently recovered and reused without obvious loss of the catalytic activity. This work will provide an economic and environmental-benign method for the construction of various indole derivatives. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2013.03.026

文献信息

• [EN] INDOLE-3-METHANAMINES USEFUL AS ANTI-DIABETIC, ANTI-OBESITY AND ANTI-ATHEROSCLEROTIC AGENTS
  申请人：THE UPJOHN COMPANY

  公开号：WO1992007829A1

  公开（公告）日：1992-05-14

  (EN) The present invention provides novel compounds which are useful in the treatment of NIDDM, obesity, hypertension or atherosclerosis. This invention encompasses a compound of formula (I), wherein R1-R6 represent a variety of substituents, and a method of treatment of the above conditions.(FR) Nouveaux composés utilisés dans le traitement du diabète sucré indépendant de l'insuline (NIDDM), de l'obésité, de l'hypertension ou de l'athérosclérose. L'invention comprend un composé de formule (I), dans laquelle R1-R6 représentent toute une variété de substituants, ainsi qu'un procédé de traitement des conditions pathologiques susmentionnées.